Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac Infiltration for Post-Endodontic Pain
NCT02923687Phase 2Completed
- Sponsor
- Islamic Azad University, Tehran Medical Sciences Branch
- Start
- Sep 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irreversible pulpitis comparing Ketorolac Group with Placebo Group (2 arms). Primary endpoint: Pain level following root canal treatment at 24 hours. Started Sep 2016; status: completed.
02
Drugs
ketorolac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT02923687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02923687.